AI Science Tracker
EN

Simon Fraser University

1 discovery from 2024

Discoveries

Learned birth-expression signature associates with later neonatal sepsis

Source check: Source checked. Not independent scientific confirmation.

Finding: Retrospective LASSO analysis of blood collected while newborns appeared healthy identified a four-gene signature associated with early-onset sepsis during the following week. A small external diagnostic check gave AUC .72, but those external samples were collected after illness onset. This does not independently validate pre-symptom screening or clinical benefit.

Technology: LASSO; sparse partial least-squares discriminant analysis

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Penalized model fitting selects and combines expression features linked to subsequent clinical status; the learned signature, not conventional differential expression alone, supplies the scoped finding.
Test and result
The prospective source cohort enrolled 720 newborns; day-of-birth expression comparisons included 14 later early-onset cases, six late-onset cases, 12 localized-infection cases and 32 healthy controls. Repeated development splits selected features; the final four-gene model used all available birth samples. The separate GSE26440 check comprised six early-onset cases and six controls.
Limitation / still unknown
Prospective sample collection does not establish that the fitted model was frozen before outcomes. The headline development AUC .94 is not a held-out future-patient estimate; Monte Carlo testing and final whole-cohort fitting are distinct analyses. External post-onset samples do not test prediction before clinical symptoms. Tiny case counts, clinical sepsis definitions and selected controls limit generalization. No prevention or causal immune-development mechanism is represented.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1016/j.ebiom.2024.105411

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Exact primary identity and scoped safe computational/clinical Methods and high-level Results; evidence access distinguished in case ledger; no operational laboratory procedures evaluated.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.